Gourlay SG - Search Results

1

Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.

Benowitz NL, Gourlay SG. Benowitz NL, et al. Among authors: gourlay sg. J Am Coll Cardiol. 1997 Jun;29(7):1422-31. doi: 10.1016/s0735-1097(97)00079-x. J Am Coll Cardiol. 1997. PMID: 9180099 Free article. Review.

2

Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine.

Hukkanen J, Gourlay SG, Kenkare S, Benowitz NL. Hukkanen J, et al. Among authors: gourlay sg. Clin Pharmacol Ther. 2005 Mar;77(3):159-69. doi: 10.1016/j.clpt.2004.10.012. Clin Pharmacol Ther. 2005. PMID: 15735610

3

Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.

Gourlay SG, Benowitz NL, Forbes A, McNeil JJ. Gourlay SG, et al. Eur J Clin Pharmacol. 1997;51(5):407-14. doi: 10.1007/s002280050222. Eur J Clin Pharmacol. 1997. PMID: 9049583

4

Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.

Gourlay SG, Benowitz NL. Gourlay SG, et al. Clin Pharmacol Ther. 1997 Oct;62(4):453-63. doi: 10.1016/S0009-9236(97)90124-7. Clin Pharmacol Ther. 1997. PMID: 9357397

5

Cardiovascular effects of carbon monoxide and cigarette smoking.

Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Zevin S, et al. Among authors: gourlay sg. J Am Coll Cardiol. 2001 Nov 15;38(6):1633-8. doi: 10.1016/s0735-1097(01)01616-3. J Am Coll Cardiol. 2001. PMID: 11704374 Free article. Clinical Trial.

6

The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Gourlay SG, Benowitz NL. Gourlay SG, et al. Drugs Aging. 1996 Jul;9(1):8-23. doi: 10.2165/00002512-199609010-00002. Drugs Aging. 1996. PMID: 8818582 Review.

7

Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimation.

Schaedeli F, Pitsiu M, Benowitz NL, Gourlay SG, Verotta D. Schaedeli F, et al. Among authors: gourlay sg. J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):49-66. doi: 10.1023/a:1015768602037. J Pharmacokinet Pharmacodyn. 2002. PMID: 12194535

8

Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum.

Pitsiu M, Gries JM, Benowitz N, Gourlay SG, Verotta D. Pitsiu M, et al. Among authors: gourlay sg. J Pharmacokinet Pharmacodyn. 2002 Aug;29(4):383-402. doi: 10.1023/a:1020957208071. J Pharmacokinet Pharmacodyn. 2002. PMID: 12518710

9

Clinical pharmacology of nicotine.

Zevin S, Gourlay SG, Benowitz NL. Zevin S, et al. Among authors: gourlay sg. Clin Dermatol. 1998 Sep-Oct;16(5):557-64. doi: 10.1016/s0738-081x(98)00038-8. Clin Dermatol. 1998. PMID: 9787965 Review. No abstract available.

10

Clonidine for smoking cessation.

Gourlay SG, Stead LF, Benowitz NL. Gourlay SG, et al. Cochrane Database Syst Rev. 2000;(2):CD000058. doi: 10.1002/14651858.CD000058. Cochrane Database Syst Rev. 2000. PMID: 10796479 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page